Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular ...
Biosion, Inc. ("Biosion"), a global, clinical-stage biotechnology company developing innovative antibody-based therapeutics, today announced that the first patient has been dosed in a Phase 1a/1b ...
STOCKHOLM, SE / ACCESS Newswire / February 3, 2026 / AlzeCure Pharma AB (publ) (FN STO:ALZCUR)(STO:ALZCUR)(FRA:AC6), a ...
Credelio Quattro combines four active ingredients to protect dogs against six parasite types, including tapeworms and ...
Even film students are struggling to sit through feature-length movies these days, but there's a way for them (and everyone else) to change that.
Explore how boron compounds are revolutionising drug development with new stable boron-fluorine compounds for better ...
Meeting with the FDA to review the results from the Phase 3 EFZO-FIT™ study and determine the path forward for efzofitimod in pulmonary ...
Atherosclerosis, the gradual buildup of cholesterol-rich plaque inside artery walls, is the driving force behind most heart ...
Learn which nanocarriers matter now (LNPs, exosomes, polymers) and the key hurdles in biodistribution, safety, CMC, and ...
STOCKHOLM, SE / ACCESS Newswire / February 3, 2026 / AlzeCure Pharma AB (publ) (FN STO:ALZCUR)(STO:ALZCUR)(FRA:AC6), a pharmaceutical company that develops candidate drugs for diseases affecting the n ...
The New Republic on MSNOpinion
Top Official Has Bonkers Defense for Trump Mentions in Epstein Files
The Trump administration is running out of excuses to explain away the president’s relationship with deceased child sex ...
Good day, everyone, and welcome to Pfizer's Fourth Quarter 2025 Earnings Conference Call. Today's call is being recorded. At ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results